Cargando…
Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
The ability of pyrazinamide to enhance the in vivo cytotoxicity of cyclophosphamide in Lewis lung and RIF-1 tumours was investigated. Using an in vivo/in vitro excision assay a large single dose of pyrazinamide (500 mg kg-1 i.p.) was shown to enhance the tumour cell killing by cyclophosphamide. This...
Autores principales: | Horsman, M. R., Chaplin, D. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968828/ https://www.ncbi.nlm.nih.gov/pubmed/8142253 |
Ejemplares similares
-
Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.
por: Chaplin, D. J., et al.
Publicado: (1990) -
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
por: Chaplin, D. J., et al.
Publicado: (1991) -
The cytotoxicity of cyclophosphamide is enhanced in combination with monascus pigment
por: Kurokawa, Hiromi, et al.
Publicado: (2021) -
Calcitriol enhances pyrazinamide treatment of murine tuberculosis
por: Zhang, Jing, et al.
Publicado: (2019) -
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
por: Chaplin, D. J., et al.
Publicado: (1993)